Key takeaways:
There are three at-home, stool-based tests for colon cancer screening.
These tests are more convenient than a colonoscopy. But they need to be done more often.
To make sure your at-home screening test can be processed correctly, you need to label the sample correctly, get a sufficient sample, and send it out as soon as possible.
At-home tests may not be a good option for people at higher risk for colorectal cancer. So be sure to talk with your provider about your risk factors.
Experts recommend colon cancer screening for most adults starting at age 45. The goal of screening is to find early cancers or precancerous polyps (growths in the colon) that can become cancerous over time. Screening for colon cancer can be life-saving. When colon cancer is found early and before it spreads, about 9 in 10 people diagnosed will be alive after 5 years.
When most people think of colon or rectal cancer screening, they think of a colonoscopy (a camera test that looks at the inside of the large intestine, or colon). While a colonoscopy is the most accurate screening tool, it’s not the only test out there. In fact, you can perform your own colorectal screening test in the comfort of your own home.
We’re here to help you understand how accurate and reliable these at-home tests are and when it’s best to visit a provider instead.
The FDA has approved three types of at-home tests for colon cancer. They work by testing a sample of your stool (feces or poop). This makes them convenient to do at home. The tests work by looking for blood or DNA in the stool that could be from colon cancer.
Most cancers bleed into the colon or rectum. You may not be able to see the blood, but colon cancer tests can detect it.
Here are the different types of at-home tests.
Guaiac fecal occult blood test (gFOBT) uses a chemical called guaiac to look for occult blood in the stool (blood that isn’t visible to the naked eye).
To do the test, you collect stool samples from three separate bowel movements. You use a stick or swab to take a small sample of stool and apply it to a test card. Your kit will come with instructions and the materials you need to collect your samples.
You need to stop certain medications (like NSAIDs), vitamin C supplements, and some foods a few days before doing the test. This is because certain foods and medications can cause false-positive or false-negative results. This means the test comes back as positive or negative when the real result is the opposite.
Like gFOBT, the fecal immunochemical test (FIT) detects blood in the stool. The difference is that it uses antibodies (instead of guaiac).
FIT is used more often than gFOBT because it’s easier to do. You only need to collect one sample, and you don’t need to stop any foods or medications before the test. FIT is also more likely to give accurate results than gFOBT.
This test checks the stool for DNA from cancerous or precancerous cells in the colon. Cancer cells (and normal cells) from the colon can be detected in the stool. The stool DNA test also checks for blood (hemoglobin).
To do the test, you’ll need to collect a whole stool sample for the test (compared to the small sample needed for gFOBT and FIT). You don’t have to change your diet or stop any medications before doing the test.
After you collect the sample, follow the specific instructions and send it back to a lab for testing. The kit will have information about how you’ll get the results.
If your healthcare provider ordered the test, they’ll get the results and then share them with you. If an at-home colon cancer test is positive, the next step should be a colonoscopy. Your provider can help you understand your results and discuss next steps with you.
A colon cancer screening test is only useful if a lab can process the sample that you send. To make sure your sample gets processed, follow the instructions carefully when collecting and sending a stool sample.
A large study found that more than 1 in 10 samples of FIT tests could not be processed by a lab. The most common reasons for this were:
Not enough stool sample
Incorrectly labeled sample
Old samples
Broken or leaking containers
This study looked specifically at FIT tests, but similar problems can happen for all kinds of at-home stool tests. Make sure to label the samples as directed and follow instructions for how much stool to include. And don’t wait long to send it to the lab. If your sample can’t be processed, send another sample.
At-home screening tests are best for people with an average risk of colon cancer. This means you don’t have risk factors for colon cancer other than age.
You have a higher risk for colorectal cancer if you have any of the following:
A history of colon cancer or polyps
A family history of colon cancer or polyps
Inflammatory bowel disease (like Crohn’s disease and ulcerative colitis)
A personal or family history of a high-risk disease (like Lynch syndrome or familial adenomatous polyposis)
If you have any of these risk factors, at-home screening tests may not be right for you. Other screening tests, like a colonoscopy, may be better. Your healthcare provider can help you decide on the best way and time to screen for colon cancer for your unique situation.
How often you screen for colon cancer depends on which at-home test you use. If you have an average risk for colon cancer, here’s the recommended timing by test:
gFOBT: every year
FIT: every year
Stool DNA testing: every 3 years
Like with most things, there are pros and cons to at-home colon cancer tests.
If you have average risk for colon cancer, at-home tests have many pros that may make them a good option for you:
Convenience: You can do at-home tests at any time. Test kits for each type of home stool-based test will give you the supplies and instructions you need.
No appointments: Compared to a colonoscopy, you don’t need to take time off from work or arrange transportation.
No bowel prep or sedation: There’s no need for bowel prep (emptying your bowel ahead of time), and the tests don’t require anesthesia or sedation like a colonoscopy.
At-home colon cancer screening needs to happen more frequently. With the gFOBT or FIT, yearly screening is recommended. With a stool DNA test, you should screen every 3 years. In comparison, a colonoscopy should be done every 10 years (if the results are normal and you don’t have other risk factors).
Beyond frequency, some people may not be comfortable handling stool samples. And you run the risk of finding out that you didn’t provide an adequate sample for testing, in which case you’ll need to provide another sample.
You can buy some colon cancer screening tests over the counter at your local pharmacy or online. You’ll need a prescription from your healthcare provider for stool-based DNA tests. But you can buy some gFOBT and FIT tests without a prescription.
To make sure you get the best test, your healthcare provider can often give you a test kit at your appointment or help you find a test that’s right for you.
While colonoscopy is the best test for colon cancer screening, at-home colon cancer tests are also accurate. FIT is better at accurately detecting colon cancer compared to gFOBT. For this reason, FIT is often preferred over gFOBT. That said, both FIT and gFOBT have been shown to decrease deaths from colon cancer.
Stool DNA tests can give positive results that aren’t really positive. The downside of this is it can lead to more colonoscopies being done for tests that aren’t actually abnormal.
Colonoscopy has a 100% detection rate for colon cancer. A provider performs a colonoscopy using a long, thin instrument with a camera on the end. This lets them see inside the colon and remove any polyps.
So how do at-home screening tests compare? For people at average risk of colon cancer, at-home stool tests can be a good alternative to colonoscopy. And doing an at-home test is much better than not screening for colon cancer at all. For people with a higher risk of colon cancer, a colonoscopy is the best screening test.
At-home colon cancer tests are only used for screening. They’re not for diagnosing colon cancer. If you have symptoms that could be from colon cancer, talk with your healthcare provider before doing any testing.
Colon cancer symptoms can include:
Weight loss
Abdominal pain
A change in bowel habits
Although these symptoms can be from colon cancer, there are also other causes. Your healthcare provider can make sure you get the right testing to figure out the correct diagnosis.
At-home, stool-based colon cancer tests are a convenient and easy way for people with an average risk to screen for colon cancer. Screening for colon cancer can help detect cancer earlier, making treatment more effective. There are different ways to screen for colon cancer, but the best type of screening is the one you and your healthcare provider decide is right for you.
American Cancer Society. (2020). Can colorectal polyps and cancer be found early?
American Cancer Society. (2020). Colorectal cancer screening tests.
American Cancer Society. (2023). Key statistics for colorectal cancer.
American Society of Clinical Oncology. (2022). Familial adenomatous polyposis.
Centers for Disease Control and Prevention. (2023). Colorectal cancer screening tests.
Centers for Disease Control and Prevention. (2023). Lynch syndrome.
Liu, P., et al. (2023). Unsatisfactory fecal immunochemical tests for colorectal cancer screening: Prevalence, reasons, and subsequent testing. Cancer Epidemiology, Biomarkers and Prevention.
National Human Genome Research Institute. (2023). Antibody.
National Human Genome Research Institute. (2023). Deoxyribonucleic acid (DNA).
National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Colonoscopy.
Robertson, D.J., et al. (2017). Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: A consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology.
Shaukat, A., et al. (2021). ACG clinical guidelines: Colorectal cancer screening 2021. The American Journal of Gastroenterology.
U.S. Preventive Services Task Force. (2021). Screening for colorectal cancer: USPSTF recommendation statement. Journal of the American Medical Association.